Owlet (OWLTW) Long-Term Investments (2020 - 2021)

Owlet (OWLTW) reported Long-Term Investments of $230.1 million for Q2 2021, little changed quarter-over-quarter from $230.1 million in Q1 2021.

Owlet (OWLTW) Long-Term Investments (2020 - 2021) Analysis & Trends

Owlet (OWLTW) has 2 years of Long-Term Investments data on file, last reported at $230.1 million in Q2 2021.

Long-Term Investments for Q2 2021 came in at $230.1 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was $230.1 million (changed N/A YoY), and the FY2020 annual result was $230.1 million, changed N/A from the prior year.
Long-Term Investments held at $230.1 million in Q2 2021 per OWLTW's latest filing, from $230.1 million in the prior quarter.
Over five years, Long-Term Investments peaked at $230.1 million in Q2 2021 and troughed at $230.0 million in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	1.09 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	285.60 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	166.25 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Owlet	-	-	12.24 Mn	-

Download Data